Literature DB >> 8546509

Lung function from infancy to school age in cystic fibrosis.

C S Beardsmore1.   

Abstract

The aim was to investigate pulmonary mechanics in patients with cystic fibrosis during infancy and again in early childhood to see whether infant tests predicted status at school age. Plethysmographic measurements of thoracic gas volume and airways resistance were made in 29 patients at 6 months and again at 5 years 10 months. Maximum flow at functional residual capacity was measured during infancy for comparison with maximum expiratory flow rates during childhood. While many patients had normal measurements during infancy, pulmonary function had deteriorated by school age. Thoracic gas volume at school age was significantly related to the values in infancy, but other measurements made during childhood were independent of infant values. The relations between measurements in infancy and early childhood described here provide a background against which the role of external factors on pulmonary function in young children with cystic fibrosis can be investigated.

Entities:  

Mesh:

Year:  1995        PMID: 8546509      PMCID: PMC1511453          DOI: 10.1136/adc.73.6.519

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  34 in total

1.  Five- to seven-year course of pulmonary function in cystic fibrosis.

Authors:  M Corey; H Levison; D Crozier
Journal:  Am Rev Respir Dis       Date:  1976-12

2.  A new apparatus for the accurate measurement of airway resistance in infancy.

Authors:  J Stocks; N M Levy; S Godfrey
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-07

3.  A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis.

Authors:  V A Loening-Baucke; E Mischler; M G Myers
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

4.  Ventilatory function in infants with cystic fibrosis. Physiological assessment of halation therapy.

Authors:  P D Phelan; M Gracey; H E Williams; C M Anderson
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

5.  Upstream and total airway conductance in children and adolescents.

Authors:  A Zapletal; M Samanek; T Paul
Journal:  Bull Eur Physiopathol Respir       Date:  1982 Jan-Feb

6.  Serial lung function studies in cystic fibrosis in the first 5 years of life.

Authors:  S Godfrey; M Mearns; G Howlett
Journal:  Arch Dis Child       Date:  1978-01       Impact factor: 3.791

7.  Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome.

Authors:  A L Coates; H Bergsteinsson; K Desmond; E W Outerbridge; P H Beaudry
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

8.  Pulmonary sequelae of neonatal respiratory distress in very low birthweight infants: a clinical and physiological study.

Authors:  Y C Wong; C S Beardsmore; M Silverman
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

9.  Evolution of pulmonary function during an acute exacerbation in hospitalized patients with cystic fibrosis.

Authors:  D Gozal; S L Bailey; T G Keens
Journal:  Pediatr Pulmonol       Date:  1993-12

10.  Nitrogen single breath test, flow-volume curves and spirometry in healthy children, 7-18 years of age.

Authors:  L Solymar; P H Aronsson; B Bake; J Bjure
Journal:  Eur J Respir Dis       Date:  1980-10
View more
  10 in total

1.  Whole body air displacement plethysmography compared with hydrodensitometry for body composition analysis.

Authors:  O Dewit; N J Fuller; M S Fewtrell; M Elia; J C Wells
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  Respiratory function in childhood following repair of oesophageal atresia and tracheoesophageal fistula.

Authors:  L Agrawal; C S Beardsmore; U M MacFadyen
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

Review 3.  Monitoring early inflammation in CF. Infant pulmonary function testing.

Authors:  Jack K Sharp
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

4.  Early airway infection, inflammation, and lung function in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood; Claire Wainwright
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

5.  Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis.

Authors:  Richard Kraemer; Philipp Latzin; Isabelle Pramana; Pietro Ballinari; Sabina Gallati; Urs Frey
Journal:  Respir Res       Date:  2009-11-12

Review 6.  Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments.

Authors:  Louise Lannefors; Brenda M Button; Maggie McIlwaine
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

7.  Initial clinical evaluation of stationary digital chest tomosynthesis in adult patients with cystic fibrosis.

Authors:  Elias Taylor Gunnell; Dora K Franceschi; Christina R Inscoe; Allison Hartman; Jennifer L Goralski; Agathe Ceppe; Brian Handly; Cassandra Sams; Lynn Ansley Fordham; Jianping Lu; Otto Zhou; Yueh Z Lee
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

Review 8.  Advantages of comprehensive lung function techniques in cystic fibrosis.

Authors:  C K van der Ent; P L Brand
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

9.  Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.

Authors:  Richard Kraemer; David N Baldwin; Roland A Ammann; Urs Frey; Sabina Gallati
Journal:  Respir Res       Date:  2006-11-30

10.  Hyperinflation is associated with increased respiratory rate and is a more sensitive measure of cystic fibrosis lung disease during infancy compared to forced expiratory measures.

Authors:  Heather N Muston; James E Slaven; Christina Tiller; Charles Clem; Thomas W Ferkol; Sarath Ranganathan; Stephanie D Davis; Clement L Ren
Journal:  Pediatr Pulmonol       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.